Knott David M Jr »

Cullinan Oncology shares owned by Knott David M Jr

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2026-03-31 $344k 24k 14.21

More positions owned by Knott David M Jr

Alphabet Inc-Cl C Common (GOOG)
Apollo Global Management Common (APO)
Syndax Pharmaceutical Common (SNDX)
Bridgebio Pharma Common (BBIO)
Protagonist Therapeutics Common (PTGX)
Xeris Biopharma Holdings Common (XERS)
JPMorgan Chase & Co. Common (JPM)
Iovance Biotherapeutics Common (IOVA)
LPL Financial Holdings Common
Janus Henderson AAA CLO ETF Common (JAAA)
Alkermes Common (ALKS)
Travere Therapeutics Common (TVTX)
Cogent Biosciences Common (COGT)
Viridian Therapeutics Common (VRDN)
Agios Pharmaceutical Common (AGIO)

View all positions for Knott David M Jr

Top funds holding Cullinan Oncology

Lynx1 Capital Management
MPM Oncology Impact Management
BVF
BlackRock
Vanguard Group
Kynam Capital Management
Vanguard Capital Management
Blue Owl Capital Holdings
State Street Corporation
Affinity Asset Advisors
Rtw Investments
VR Adviser
Geode Capital Management
Siren
Nextech Invest

View all funds holding Cullinan Oncology